Prosonix Initiates Phase 2 Clinical Study with PSX1002 in COPD Patients

News   May 23, 2013

 
Prosonix Initiates Phase 2 Clinical Study with PSX1002 in COPD Patients
 
 
 
FURTHER INFORMATION
 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 
 

Comments | 0 ADD COMMENT